Information about Storms Pharma
My details
*
*
*

Storms Pharma (SRL)

BE 0683.469.918

Leo Kempenaersstraat 7, 2223 Heist-op-den-Berg

Company information

Status
Active

Enterprise number

BE0683.469.918

VAT liability
Yes
Established
18-10-2017
Last balance sheet year
2024
Company size
Medium-sized 0 FTE
Principal activity
Activities of holding companies
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Storms Pharma

2024 2023 2022 2021
Profit/Loss € 183,555 5 % € 174,146 -15 % € 204,173 74 % € 117,585
Equity € 778,197 -5 % € 823,373 23 % € 669,227 39 % € 480,053
Gross margin € 62,102 -3 % € 63,711 11 % € 57,330 -4 % € 59,613

Publications from Storms Pharma

Date Publication
25-10-2021 Modification Legal Form - Resignations - Appointments (NL)
20-10-2017 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Storms Pharma?
The VAT number of Storms Pharma is BE 0683.469.918.
Wat is the PEPPOL ID of Storms Pharma?
The PEPPOL ID of Storms Pharma is 0208:0683469918. Log in or start a free trial to see the full overview.
When was Storms Pharma founded?
Storms Pharma was founded on 18-10-2017.
What is the address of Storms Pharma?
The current registered office of Storms Pharma is located at Leo Kempenaersstraat 7, 2223 Heist-op-den-Berg.
When was the last time Storms Pharma filed their annual financial statements?
The most recent financial statements of Storms Pharma were filed on 04-07-2025.
How many employees does Storms Pharma have?
There are currently no employees working at Storms Pharma or no workforce information is available.
What is the annual turnover of Storms Pharma?
At the time of its most recent financial statements, Storms Pharma did not publish any turnover figures. Storms Pharma reported a gross margin of €62,102.32.

Sources